| # | Title | Journal | Year | Citations |
|---|
| 1 | Auranofin: Repurposing an Old Drug for a Golden New Age | Drugs in R and D | 2015 | 384 |
| 2 | Immunosuppressive and Anti-Inflammatory Mechanisms of Triptolide, the Principal Active Diterpenoid from the Chinese Medicinal Herb Tripterygium wilfordii Hook. f. | Drugs in R and D | 2003 | 271 |
| 3 | Clinical and Experimental Applications of Sodium Phenylbutyrate | Drugs in R and D | 2011 | 220 |
| 4 | A Guide to Medications Inducing Salivary Gland Dysfunction, Xerostomia, and Subjective Sialorrhea: A Systematic Review Sponsored by the World Workshop on Oral Medicine VI | Drugs in R and D | 2017 | 208 |
| 5 | Benzodiazepines and Z-Drugs: An Updated Review of Major Adverse Outcomes Reported on in Epidemiologic Research | Drugs in R and D | 2017 | 181 |
| 6 | Applications of Metabolomics in Drug Discovery and Development | Drugs in R and D | 2008 | 174 |
| 7 | Effect of NCB-02, Atorvastatin and Placebo on Endothelial Function, Oxidative Stress and Inflammatory Markers in Patients with Type 2 Diabetes Mellitus | Drugs in R and D | 2008 | 158 |
| 8 | Lipid Peroxidation and Cataracts | Drugs in R and D | 2004 | 149 |
| 9 | Effect of Dexmedetomidine on Haemodynamic Responses to Laryngoscopy and Intubation | Drugs in R and D | 2006 | 138 |
| 10 | Axitinib for the Management of Metastatic Renal Cell Carcinoma | Drugs in R and D | 2011 | 130 |
| 11 | An Updated Overview on Therapeutic Drug Monitoring of Recent Antiepileptic Drugs | Drugs in R and D | 2016 | 130 |
| 12 | Potential Risks of Pharmacy Compounding | Drugs in R and D | 2013 | 128 |
| 13 | Salvia (Sage): A Review of its Potential Cognitive-Enhancing and Protective Effects | Drugs in R and D | 2017 | 128 |
| 14 | Acetyl-L-Carnitine (Levacecarnine) in the Treatment of Diabetic Neuropathy | Drugs in R and D | 2002 | 127 |
| 15 | Content of Botulinum Neurotoxin in Botox®/Vistabel®, Dysport®/Azzalure®, and Xeomin®/Bocouture® | Drugs in R and D | 2010 | 125 |
| 16 | Second-Generation Antipsychotics and Neuroleptic Malignant Syndrome: Systematic Review and Case Report Analysis | Drugs in R and D | 2015 | 125 |
| 17 | Electrophysiological Effects of a Single Intravenous Administration of Ivabradine (S 16257) in Adult Patients with Normal Baseline Electrophysiology | Drugs in R and D | 2003 | 123 |
| 18 | Topical Rapamycin Therapy to Alleviate the Cutaneous Manifestations of Tuberous Sclerosis Complex | Drugs in R and D | 2012 | 120 |
| 19 | ??-Secretase Inhibitors for Alzheimer??s Disease | Drugs in R and D | 2006 | 113 |
| 20 | Pharmaceutical, Biological, and Clinical Properties of Botulinum Neurotoxin Type A Products | Drugs in R and D | 2015 | 110 |
| 21 | Comparative Pharmacology of Risperidone and Paliperidone | Drugs in R and D | 2015 | 106 |
| 22 | Effects of Antioxidant Vitamins on Glutathione Depletion and Lipid Peroxidation Induced by Restraint Stress in the Rat Liver | Drugs in R and D | 2005 | 105 |
| 23 | Adverse Event Profile of Pyrimethamine-Based Therapy in Toxoplasmosis: A Systematic Review | Drugs in R and D | 2017 | 101 |
| 24 | Volume Efficacy and Reduced Influence on Measures of Coagulation Using Hydroxyethyl Starch 130/0.4 (6%) with an Optimised in???Vivo???Molecular Weight in Orthopaedic Surgery | Drugs in R and D | 2004 | 100 |
| 25 | Ketamine as a Potential Treatment for Suicidal Ideation: A Systematic Review of the Literature | Drugs in R and D | 2015 | 99 |
| 26 | Bortezomib for the Treatment of Hematologic Malignancies: 15 Years Later | Drugs in R and D | 2019 | 98 |
| 27 | Can Nasal Drug Delivery Bypass the??Blood-Brain Barrier? | Drugs in R and D | 2007 | 95 |
| 28 | Improving Early Drug Discovery through ADME Modelling | Drugs in R and D | 2007 | 91 |
| 29 | Intra-Articular Injections for the Treatment of Osteoarthritis | Drugs in R and D | 2011 | 89 |
| 30 | Dabigatran Versus Warfarin After Bioprosthesis Valve Replacement for the Management of Atrial Fibrillation Postoperatively: DAWA Pilot Study | Drugs in R and D | 2016 | 89 |
| 31 | Preclinical Pharmacology of Bilastine,??a New Selective Histamine??H1 ??Receptor Antagonist | Drugs in R and D | 2005 | 87 |
| 32 | Efficacy of Rebamipide as Adjunctive Therapy in the Treatment of Recurrent Oral Aphthous Ulcers in Patients with Beh??et??s Disease | Drugs in R and D | 2003 | 85 |
| 33 | Poly (ADP-Ribose) Polymerase Inhibitors: Talazoparib in Ovarian Cancer and Beyond | Drugs in R and D | 2020 | 84 |
| 34 | The Potential of Plant Virus Vectors for Vaccine Production | Drugs in R and D | 2006 | 82 |
| 35 | Identification of a Potential Peptide Inhibitor of SARS-CoV-2 Targeting its Entry into the Host Cells | Drugs in R and D | 2020 | 80 |
| 36 | Topical Ketoprofen Patch | Drugs in R and D | 2005 | 76 |
| 37 | Hydroxyethyl Starch (HES) [130/0.4],??? a New HES Specification | Drugs in R and D | 2003 | 75 |
| 38 | Efficacy of N-Acetylcarnosine in the Treatment of Cataracts | Drugs in R and D | 2002 | 72 |
| 39 | C60 Fullerene as Synergistic Agent in Tumor-Inhibitory Doxorubicin Treatment | Drugs in R and D | 2014 | 69 |
| 40 | Switching Between Biological Treatments in Psoriatic Arthritis: A Review of the Evidence | Drugs in R and D | 2017 | 69 |
| 41 | Hemostatic Effects of a Novel Estradiol-Based Oral Contraceptive | Drugs in R and D | 2011 | 68 |
| 42 | EGb 761 | Drugs in R and D | 2003 | 66 |
| 43 | mTOR: A Potential Therapeutic Target in Osteoarthritis? | Drugs in R and D | 2015 | 62 |
| 44 | In Vivo Pharmacological Characterisation of Bilastine, a Potent??and Selective Histamine H1??Receptor Antagonist | Drugs in R and D | 2006 | 61 |
| 45 | Eslicarbazepine Acetate: A New Improvement on a Classic Drug Family for the Treatment of Partial-Onset Seizures | Drugs in R and D | 2017 | 61 |
| 46 | Tissue Storage of 14 C-Labelled Hydroxyethyl Starch (HES) 130/0.4 and HES 200/0.5 after Repeated Intravenous Administration to Rats | Drugs in R and D | 2003 | 60 |
| 47 | Molecular Insight in the Multifunctional Effects of Oridonin | Drugs in R and D | 2015 | 60 |
| 48 | Adaptive Clinical Trials | Drugs in R and D | 2008 | 59 |
| 49 | Selective Phosphodiesterase (PDE)-4 Inhibitors | Drugs in R and D | 2006 | 56 |
| 50 | Influence of Piperine on the Pharmacokinetics of Nevirapine under Fasting Conditions | Drugs in R and D | 2007 | 55 |
